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The retina is a highly sophisticated piece of the neural machinery that begins the trans-
lation of incoming light signals into meaningful visual information. Several degenerative
diseases of the retina are characterized by photoreceptor loss and eventually lead to irre-
versible blindness. Regenerative medicine, using tissue engineering-based constructs to
deliver progenitor cells or photoreceptors along with supporting carrier matrix is a promis-
ing approach for restoration of structure and function. Fresh fibrin glue (FG) produced by
the CryoSeal®FS system in combination with mouse retinal progenitor cells (RPCs) were
evaluated in this study. In vitro expanded RPCs isolated from postnatal mouse retina were
encapsulated into FG and cultured in the presence of the protease inhibitor, tranexamic
acid. Encapsulation of RPCs into FG did not show adverse effects on cell proliferation or cell
survival. RPCs exhibited fibroblast-like morphology concomitantly with attachment to the
encapsulating FG surface. They expressed α7 and β3 integrin subunits that could mediate
attachment to fibrin matrix via an RGD-independent mechanism. The three-dimensional
environment and the attachment surface provided by FG was associated with a rapid
down-regulation of the progenitor marker SOX2 and enhanced the expression of the
differentiation markers cone-rod homeobox and recoverin. However, the in vitro culture
conditions did not promote full differentiation into mature photoreceptors. Nevertheless,
we have shown that autologous fibrin, when fabricated into a scaffold for RPCs for deliv-
ery to the retina, provides the cells with external cues that could potentially improve the
differentiation events. Hence, transient encapsulation of RPCs into FG could be a valid
and potential treatment strategy to promote retinal regeneration following degenerative
diseases. However, further optimization is necessary to maximize the outcomes in terms
of mature photoreceptors.
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INTRODUCTION
The retina is the highly specialized, multi-layered light-sensitive
neural tissue located at the back of the eye that receives visual
stimuli and converts it into chemical and electrical signals that
are interpreted by the brain for sight (Inoue et al., 2010; Karl and
Reh, 2010). The retina is susceptible to a range of degenerative dis-
eases, the most common being age-related macular degeneration
(AMD), diabetic retinopathy (DR), and genetic diseases such as
retinitis pigmentosa (RP) (Ballios et al., 2010). Vision loss asso-
ciated with AMD and RP is caused by loss of function or death
of photoreceptors. Hence, most therapies for these conditions aim
to prevent photoreceptor loss or restore photoreceptor function
(Ballios et al., 2010). Two main routes are being explored: the
replacement of the photoreceptor with electronic visual implants
that transmit electrical signals to the brain (Zrenner, 2002); and
cell-based therapies including retinal transplantation (Pritchard
et al., 2010; Taylor et al., 2013) or transplantation of photoreceptor
precursors (MacLaren et al., 2006).
Delivery of healthy autologous or allogeneic cells that have the
capacity to integrate with the host retina and replace photore-
ceptor function to the subretinal space is a promising strategy to
restore vision (Banin et al., 2006; West et al., 2008; Ballios et al.,
2010; Mansergh et al., 2010). A wide range of cells types including
progenitor cells, mature photoreceptors, retinal sheets, and retinal
pigmented epithelial cells have been delivered to the subretinal
space and show variable degrees of vision improvement in ani-
mal models (Hynes and Lavik, 2010). It has been demonstrated
that delivery of retinal progenitor cell (RPC) suspensions into the
subretinal space in the absence of supporting scaffold results in
insufficient cell survival (Tomita et al., 2005; Ballios et al., 2010),
leakage, and migration from the injection site (Ballios et al., 2010).
Evidence to date suggests that transient encapsulation of cells
for delivery enhances their survival under the adverse conditions
within the disease or injury-damaged host target organs (Karoubi
et al., 2009; Mayfield et al., 2014). Transplantation of RPCs along
with a supporting three-dimensional scaffold has indeed been
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shown to improve cell survival, retention, differentiation, orga-
nization (Hynes and Lavik, 2010), and integration (Ballios et al.,
2010; Hynes and Lavik, 2010).
A range of biomaterials have been evaluated as scaffolds for tis-
sue engineering in general, and the retina in particular. The most
promising scaffolds for cell delivery are hydrogels that emulate the
extracellular matrix (ECM), and specifically, injectable hydrogels
that will deliver RPCs to the target site. While the use of ECM
macromolecules and other biomaterials are promising, such as
hyaluronic acid and methylcellulose (Ballios et al., 2010), the safety
and efficacy of these materials will need to be validated before
they can be evaluated in humans. Biocompatibility and immune
compatibility are critical considerations in the development of
any biomaterials-enabled therapy. Thus, a therapy that relies on
biomaterials that originates from each patient would therefore
mitigate these issues.
In studies on RPE transplantation, adhesion to ECM com-
ponents can be improved through enhancing integrin function
(Fang et al., 2009; Afshari et al., 2010), suggesting that targeting
integrin-based adhesion might also be a strategy to modulate reti-
nal progenitor survival and differentiation. Thus in this study, we
have focused our research on fibrin glue (FG), since it can be iso-
lated autologously in a crude form from patients, and fabricated
into a hydrogel scaffold without the potential risk of foreign body
reaction or infection (Ahmed et al., 2011) and would promote
integrin-based adhesion. With the advent of induced pluripoten-
tial stem cells, it may become possible to also use autologous
cells from the patients to avoid immune compatibility effects
as recent developments in iPS-derived retinal cells and tissues
(Cyranoski, 2014; Kamao et al., 2014; Reichman et al., 2014). We
have previously examined the use of FG (extracted from patient
plasma through apheresis and processed to obtain fibrinogen and
thrombin) as a scaffold for use in cartilage tissue engineering,
in combination with bone marrow-derived human mesenchymal
stem cells (BM–hMSCs) (Ahmed et al., 2011). In the eye, human
fetal retinal pigment epithelial (HFRPE) cells have been grown on
crosslinked fibrin microsphere for subretinal delivery into a rabbit
model, where they survived for over 1 month (Oganesian et al.,
1999). Here, we evaluated the use of a cell delivery system com-
prising autologous FG. This is produced by cryoprecipitation of
fibrinogen and thrombin from patient plasma, with subsequently
mixing to form a fibrin sealant. We hypothesized that transient
encapsulation of RPCs within the FG preparation could promote
enhanced proliferation and differentiation.
MATERIALS AND METHODS
MATERIALS
Fibrin glue was obtained autologously as described below. The
peptides, GRGDSP and GRGESP (sterile-filtered HPLC grade),
were purchased from Bachem Bioscience, Inc. (Torrance, CA,
USA) while RGDS (sterile-filtered HPLC grade) was purchased
from Tocris Bioscience, Inc. (Bristol, UK). Bromodeoxyuridine
(BrdU) reagent was purchased from Roche Applied Science (Mis-
sissauga, ON, Canada). Tissue culture media, L-glutamine, and
penicillin/streptomycin were purchased from Invitrogen (Life
Technologies, Burlington, ON, Canada). All other materials were
obtained from Sigma-Aldrich (Oakville, ON, Canada).
FIBRIN GLUE PRODUCTION
With ethical approval from the Ottawa Hospital Research Ethics
Board, and written, informed consent, 250 mL of pooled human
plasma was collected from two healthy donors by apheresis using
the Trima Accel Version 5 automated blood collection system
(Gambro BCT, Lakewood, CO, USA). Other blood components,
such as cells, were returned to the circulation (Ahmed et al., 2011).
FG is composed of two components – fibrinogen and thrombin.
Cryoprecipitates of fibrinogen and thrombin were obtained using
the CryoSeal®FS System and associated Thrombin Processing
Device™, respectively (ThermoGenesis Corp., Rancho Cordova,
CA, USA). These devices produce cryoprecipitated fibrinogen at a
concentration of ~20.1 mg/mL, and thrombin at ~38 U/mL. Each
component was aliquoted and stored frozen at −80°C until used
(Ahmed et al., 2011).
RETINAL PROGENITOR CELL ISOLATION AND CULTURE
Animal work was performed in accordance to the Association
for Research in Vision and Ophthalmology (ARVO) Statement
for the Use of Animals in Ophthalmic and Vision Research.
Mouse RPCs were isolated and cultured as previously described
(Ringuette et al., 2014). Briefly, eyes of euthanized neonatal
C57BL/6 mice at postnatal day 0 (PN0) or day 1 (PN1) were
dissected in CO2-independent DMEM medium. The sclera, lens,
and retinal pigment epithelium were removed, and the remain-
ing neural retinas were transferred onto 13 mm polycarbonate
filters (0.8µm pore size, Nucleopore). The explants were flat-
tened and cultured with the ganglion cell layer facing up within
24-well plates at 8% CO2 and 100% humidity. Each well was sup-
plemented with 0.5 mL of serum-free retinal cell culture medium
[SFRCM; DMEM/F12 (1:1)], 10µg/mL insulin, 100µg/mL trans-
ferrin, 100µg/mL bovine serum albumin (BSA Fraction V),
60 ng/mL progesterone, 16µg/mL putrescine, 40 ng/mL sodium
selenite, 25µg/mL gentamicin, and 20 nM Smoothened agonist
(Hh agonist) (Frank-Kamenetsky et al., 2002), a gift from Curis
Inc., Lexington, MA, USA. After 2 days, the retinal explants were
digested in 1 mL of trypsin solution (0.75µg/mL, Sigma) at 37°C
for 10 min. The digestion was stopped by the addition of 1 mL
trypsin inhibitor (1 mg/mL in SFSCM) followed by trituration to
single cells. The cell suspension was centrifuged at 1500 rpm for
5 min and the pellet was re-suspended in serum-free stem cell cul-
ture medium [SFSCM; DMEM/F12 (1:1), 6 ng/ml progesterone,
5 ng/mL selenium, 100µg/mL transferrin, 9.5µg/mL putrescine,
250µg/mL insulin, 25 ng/mL human epidermal growth factor
(EGF), 10 ng/mL fibroblast growth factor 2 (FGF-2), and 2µg/mL
heparin (Tropepe et al., 2000) supplemented with 5 nM Hh ago-
nist]. The cells were cultured in 6-well plates at the density
of 5–10× 105 cells per well in 2 mL of SFSCM or in 24-well
plates at a density of 5–10× 104 cells per well in 0.5 mL of
SFSCM. The medium was refreshed every 2 or 3 days. After
2 weeks, a monolayer formed and the cultures were passaged
every 2–3 days by mechanical trituration to obtain single cells
that were then diluted 1:3 with fresh culture medium. Differ-
entiated neurons did not survive under these culture conditions
and were lost upon serial passaging of the cultures (Ringuette
et al., 2014). Seven batches of RPCs were used during the whole
study.
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ENCAPSULATION OF RETINAL PROGENITOR CELLS IN FIBRIN GLUE
Figure 1 summarizes the preparation of fibrin-encapsulated RPCs.
Aliquots of cryoprecipitated fibrinogen (42.5µL) and 15µL cul-
tured RPCs were gently but thoroughly mixed. Polymerization
was initiated by mixing in of 42.5µL of thrombin (from same
unit as cryoprecipitate) to a final volume of 100µL of gel. Final
concentrations of fibrinogen, thrombin, and cells within each
gel were ~8 mg/mL, ~13 U/mL, and 107 cells/mL, respectively.
Resulting hydrogels were disk-shaped constructs 6.5 mm diam-
eter and 2 mm thick. After incubation for 30 min at 37°C to allow
optimum coagulation, gels were cultured in Transwell® culture
inserts and supplemented with SFSCM medium containing 5 nM
Hh agonist and 1.5 mg/mL tranexamic acid (protease inhibitor).
Implants were maintained at 37°C in a humidified incubator with
5% CO2 for up to 7 days with media changed every 3–4 days. In
the absence of protease inhibitors, fibrin gels completely degraded
over 2–3 days in culture; however, the gels were fully stabilized by
addition of tranexamic acid to the medium. At 0, 1, 3, and 7 days,
gels were collected for immunohistochemical evaluation or RNA
isolation.
FIGURE 1 | Diagram showing the preparation of fibrin-encapsulated
RPCs. Aliquots of cryoprecipitated fibrinogen and thrombin, and retinal
progenitor cells were combined and allowed to polymerize (with thrombin
serving as a cross-linker). The encapsulated cells were then cultured in
serum-free media with additives such as sonic hedgehog agonist,
tranexamic acid, and BrdU.
IMMUNOHISTOCHEMISTRY
Fibrin glue-RPC constructs (FG-RPCs) were examined for the
expression of integrin α7, which is upregulated when cells bind
to ECM macromolecules, SRY related HMG BOX gene 2 (SOX2),
which marks RPCs (Steedman et al., 2010), and photoreceptor-
specific markers – recoverin (RC), cone-rod homeobox (CRX),
and rhodopsin, which is found only in mature rod photoreceptors.
Fibrin hydrogels containing RPCs were fixed in 4%
paraformaldehyde for 30 min at room temperature, cryoprotected
in 30% sucrose for 24 h, and then frozen in 1:1, 30% sucrose: OCT
and stored at−80°C. Cryosections of 10µm thickness were placed
onto slides and stored at−80°C. Cultured monolayers of cells were
fixed in 4% paraformaldehyde for 30 min at 4°C then washed two
times in 0.1 M phosphate buffered saline (PBS; pH7.4), and stored
at 4°C. For immunohistochemistry, slides with frozen sections
were equilibrated to room temperature and washed three times
in PBS (5 min each) prior to incubating in blocking buffer (PBS
containing 5% heat-inactivated fetal bovine serum and 1% bovine
serum albumin) for 1 h to prevent non-specific antibody binding.
After blocking, slides were washed again in PBS, and then incu-
bated overnight at 4°C in one of the following primary antibodies:
SOX2, RC, CRX, rhodopsin, and integrin α7, prepared in blocking
buffer plus 0.3% Triton X-100 (PBST). Details of the antibodies
and dilutions used are listed in Table 1. The next morning, the
slides were washed three times in PBS and incubated with the sec-
ondary antibody prepared in PBST for 1 h at room temperature.
After a further two washes in PBS, the slides were stained for 3 min
with DAPI stain (1:10,000 in PBS), washed again twice in PBS, and
cover-slipped with PBS for visualization using a Nikon Eclipse
TE2000-E microscope (Nikon Instruments, Inc.) and accompa-
nying software (NIS-Elements™ AR3.10). For negative controls,
the primary antibody was omitted. For positive controls of SOX2
and RC (early RPC markers), PN0 mouse eyes were used, while
for CRX and rhodopsin (late stage marker) and integrins, adult
mouse eyes served as positive controls.
EFFECTS OF FIBRIN AND TRANEXAMIC ACID ON CELL VIABILITY AND
PROLIFERATION
The effects of fibrin and tranexamic acid on cell viability and pro-
liferation were examined. To label proliferating cells, RPC encap-
sulated in fibrin hydrogels were prepared and cultured as described
above. Ten µM BrdU was added to the culture medium to label
cells in S-phase. For BrdU staining of cells or cyro-sectioned
Table 1 | Antibodies used for immunohistochemistry.
No. Antibody Host Type Final concentration Company and catalog number
1 Anti-BrdU antibody Mouse Monoclonal 1:500 A21300, Invitrogen
2 Anti-SOX2 antibody Rabbit Polyclonal 1:200 AB5603, Millipore
3 Anti-RC antibody Rabbit Polyclonal 1:500 AB5585, Millipore
4 Anti-CRX antibody Rabbit Polyclonal 1:50 Gift from Dr. C. Gregory-Evans
5 Anti-rhodopsin antibody Mouse Monoclonal 1:50 B630, Developmental Studies Hybridoma Bank
6 Anti-integrin α7 antibody Mouse Monoclonal 1:50 K0046-3, MBL International Company
7 Anti-mouse IgG (H+L) antibody, Alexa
Fluor®488 (green)
Goat Polyclonal 1:400 A11029, Invitrogen
8 Anti-rabbit IgG (H+L) antibody, Cy3™
conjugate (red)
Goat Polyclonal 1:500 111-165-003, Jackson ImmunoResearch
Laboratories
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material, slides were equilibrated to room temperature, washed
three times in PBS (5 min each), and then incubated in 1N HCl
for 10 min on ice, followed by incubation in 2N HCl for 10 min
at room temperature and then 20 min at 37°C. Immediately after
the acid washes, the slides were treated with 0.1 M borate buffer
(pH 8.5) for 12 min at room temperature then washed twice in PBS
(5 min each). The sections were incubated with anti-BrdU primary
antibody (as per Table 1) and then processed as described above. In
order to determine the viability of encapsulated RPCs, apoptotic
cells were detected using the ApopTag® Fluorescein in situ apop-
tosis detection kit (S7110; Millipore) following the manufacturer’s
protocol.
ADHESION OF RETINAL PROGENITOR CELLS TO FIBRIN
Two major classes of adhesion sites have been identified in
the fibrin (ogen) molecule. One of them is mediated by RGD
sequences within the α chain of fibrinogen, while the other site
is RGD-independent (Chernousov and Carey, 2003). To identify
the site that was directing the adhesion and spreading of RPCs
onto fibrinogen, cells were plated on fibrinogen-coated plates
(Chernousov and Carey, 2003) and maintained in the previously
mentioned culture media containing different concentrations (0,
10, 25, 50, and 100µM) of either of the RGD peptides (GRGDSP
and RGDS) and compared to cells plated on fibrinogen in the
presence of a control non-RGD peptide (GRGESP). Data were
expressed as mean± SE. A two-way analysis of variance (ANOVA)
for RPCs binding to FG-coated plates in the presence of different
peptides was performed using Stata Statistical Software (Stata-
Corp LP, Release 11, 2009. College Station, TX, USA). To make
the most conservative conclusions regarding significance of the
results, Bonferroni post hoc tests were performed, as this is a very
stringent test to compare means of the different study groups.
Results were considered significant when ANOVA was confirmed
by Bonferroni post hoc test at p< 0.05.
REAL-TIME POLYMERASE CHAIN REACTION
Mouse-specific primers for SOX2, CRX, integrin α7, integrin
β3, and the control glyceraldehyde-3-phosphate dehydrogenase
(GAPDH ) were obtained from SABioscience (Qiagen Inc., Mis-
sissauga, ON, Canada) and are described in Table 2. RNA was
extracted from fibrin-encapsulated RPCs at different time points
using the RNeasy Fibrous Tissue Kit (Qiagen) and following the
manufacturer’s protocol. First-strand cDNA was synthesized using
ThermoScript™ RT-PCR system for first-strand cDNA synthesis
kit as per manufacturer’s instructions. Polymerase chain reac-
tion amplification and melt curve analysis were performed using
a BioRad iCycler thermocycler as previously described (Ahmed
et al., 2011).
The results were analyzed using the comparative CT method.
Monolayer RPCs culture was used as a baseline for each gene,
which was normalized to GAPDH housekeeping expression.
Data were used to compare gene expression at 0, 1, 3, and
7 days with triplicate determinations of four independent cul-
tures (n= 4). The ∆∆CT was calculated using the equation:
∆∆CT=∆CT(target)−∆CT(baseline). The relative gene expression
level was determined by calculating 2(−∆∆CT). The identity of
the DNA products obtained at the end of real-time PCR cycles
was confirmed using 4% agarose gel and GelGreen™ DNA dye
by comparing to data stated in the manufacturer’s protocol. Data
were expressed as mean± SE.
RESULTS
EFFECTS OF FG AND TRANEXAMIC ACID ON CELL VIABILITY,
PROLIFERATION, AND DIFFERENTIATION
Since the main problem of subretinal injection of RPCs is the
poor cell survival (Tomita et al., 2005; Ballios et al., 2010), the
effect of FG encapsulation on RPCs survival and proliferation, in
the presence of tranexamic acid, was investigated in this study.
The 7-day time course was chosen based on the differentia-
tion kinetics of perinatal rodent precursor cells in vitro (Kelley
et al., 1994; Morrow et al., 1998). Within the fibrin capsules,
RPCs initially had a rounded morphology (Figure 2A). However,
over the 7-day culture period, the cells moved out of the cap-
sules and attached to the substratum (Figures 2B–D), where they
assumed a more spread-out morphology, similar to that of cells in
monolayer cultures (Figure 2E). The BrdU assay results showed
that neither fibrin-encapsulation nor the addition of tranexamic
acid to the culture medium had any effect on RPC proliferation
(Figure 3A). Conversely, TUNEL assay results showed that nei-
ther fibrin-encapsulation nor addition of tranexamic acid to the
culture medium resulted in any increase in incidence of apoptosis
(Figure 3B).
Immunohistochemistry performed on FG-encapsulated RPCs
compared to non-encapsulated controls to compare the effects of
the encapsulation on cell behavior, shows that the retinal stem cell
markers were retained early on during the culture. Positive stain-
ing for both SOX2 and RC, a photoreceptor marker, was observed
in sections of FG-RPCs constructs at days 0, and 3 of culture
(Figure 4). However, by day 7, expression of SOX2 and RC has
dropped of considerably (Figure 4). RPCs encapsulated within
fibrin were positive for CRX at day 0 (Figure 5). The expression on
days 1 and 3 appears to be weaker but was strong again by day 7.
Table 2 | Primers used for PCR.
Target gene Gene symbol Accession no. AnnealingT (°C) Band size (bp) Catalog number
Glyceraldehyde-3-phosphate dehydrogenase GAPDH NM_008084.2 60 140 330001-PPM02946E
SRY-box containing gene 2 SOX2 NM_011443.3 60 110 330001-PPM04762E
Cone-rod homeobox containing gene CRX NM_007770.4 60 191 330001-PPM25460A
Integrin alpha 7 ITGA7 NM_008398.2 60 182 330001-PPM03611E
Integrin beta 3 ITGB3 NM_016780.2 60 67 330001-PPM03687E
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FIGURE 2 | Retinal progenitor cells cultured in fibrin hydrogels.
(A) RPCs after encapsulation, showing an initial rounded morphology. (B–D)
RPCs at days 1, 3, and 7 showing attachment and spread. (E) Control RPCs
cultured as monolayer on tissue culture plastic.
Integrins are transmembrane proteins that modulate cell adhe-
sion, proliferation, and differentiation. They initiate cell signaling
pathways upon interaction with the ECM (Welser et al., 2007). We
identified two integrins that were expressed by RPCs when plated
onto fibrin-coated plates,α7 and β3. The expression of integrin α7
was weak initially, but became more pronounced on days 3 and 7.
The RPCs that were seeded as monolayers on top of a fibrin sub-
strate showed strong immunostaining for integrin α7 (Figure 5).
Rhodopsin, which is only expressed by mature photoreceptors,
however, was negative at all time points, in both encapsulated and
non-encapsulated RPCs (data not shown). These results indicated
that contact of RPCs with FG induced cell spreading and improved
expression of two integrin subunits (α7 and β3) and early (CRX
and RC) but not late stage differentiation markers (rhodopsin).
RPC ADHESION TO FG
There was no significant change in the mean value of numbers
of attached and spread cells on fibrin substrates with the intro-
duction of increasing concentrations of competing RGD peptides
GRGDSP or RGDS (p= 0.18, F = 1.77). The line graph indicated
that adhesion and spreading of RPCs onto fibrin – coated plates
in the presence of RGD peptides were comparable to that of cells
plated in the presence of the control non-RGD peptide. As high
as 100µM of the aforementioned RGD peptides were unable
to inhibit RPCs adhesion and spreading onto fibrinogen-coated
plates when compared to cells cultured on fibrinogen-coated plate
in the presence of comparable concentration of non-RGD pep-
tide (Figure 6), suggesting that the binding of RPCs to the FG
FIGURE 3 | (A) Localization of proliferating retinal progenitor cells that have incorporated BrdU; (B) localization of apoptotic cells using the TUNEL assay.
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FIGURE 4 | Expression of (A) SOX2, which is expressed in early
retinal progenitor cells, and (B) recoverin, which is expressed by
presumptive photoreceptors (cones) in the developing retina, by
retinal progenitor cells encapsulated in fibrin glue (FG) at different
time points after placing in cell culture. C, choroid; RL, retinal layers;
VH, vitreous humor. Negative controls comprise omission of the primary
antibody; positive controls comprise sections through postnatal day 0
mouse eyes.
substrate is most likely through a mechanism that is independent
of RGD.
EFFECT OF FG ON RPC PHENOTYPE
The effects of FG on the phenotype of encapsulated RPCs was
characterized by examining the expression of markers for progeni-
tor cells versus early differentiation (SOX2 and CRX, respectively),
and expression of transmembrane receptors that mediate cell–
ECM interactions (integrin subunits α7 and β3). Directly after
encapsulation of RPCs into FG (i.e., day 0), SOX2 gene expres-
sion did not show noticeable change compared to expression in
monolayer RPCs culture. However, over the ensuing week, SOX2
gene expression declined compared to day 0 construct. In contrast,
encapsulation of RPCs into FG resulted in sevenfold initial increase
in CRX expression (days 0 and 1). However, this enhanced expres-
sion was diminished at later time points – day 3 and day 7 (two and
threefold, respectively). We evaluated the gene expression of two
integrins, α7 and β3 subunits. The encapsulation of RPCs into FG
resulted in no increase in integrin α7 gene expression directly after
encapsulation into FG (day 0). A sixfold increase was observed at
24 h post encapsulation (day 1). However, this increased α7 gene
expression did not last, as expression decreased again at days 3 and
7 (twofold increase at both time points). Integrin β3 expression
showed a marked 11- and 13-fold increase at days 0 and 1, respec-
tively. However, the expression was decreased to threefold at day 3
and day 7 time points (Figure 7).
DISCUSSION
BIOCOMPATIBILITY OF FG-TRANEXEMIC ACID SCAFFOLDS
Our results showed that encapsulation of RPCs with fibrin pre-
cursors that can be potentially isolated from autologous sources
allows the cells to proliferate and differentiate, albeit, not to full
maturity in vitro. Encapsulation of RPCs into FG did not affect
cell proliferation, nor was it cytotoxic in our study. The absence of
cytotoxic effects in our system is consistent with previous studies
that reported the safety of FG when used with the different retinal
cell types or implanted into different ocular regions (Robinson and
Madison, 2000; Pardue et al., 2004). However, it should be noted
that not all FG is similar, as the use of xenogeneic FG (porcine glue
in rabbits with human retinal pigment epithelium cells), caused
acute inflammation that resulted in fibrosis (Hou et al.,2009). Nev-
ertheless, FG has been successfully used as an adhesive substrate for
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FIGURE 5 | Immunohistochemistry, showing positive staining for CRX
(red) and integrin α7 (green) in RPCs after encapsulation into FG at
the different time points. Positive controls for CRX are cryosections of
adult mouse eyes. Positive control for integrin α7 are adult mouse orbital
muscle sections. Monolayer RPCs attached to fibrin-coated plates serve
as a second positive control for integrin α7. The negative control for CRX
and α7 are immunostained cryosections of FG-RPC constructs with the
omission of the primary antibody.
attachment of peripheral nerve grafts to optic nerve stumps, and
is permissive for retinal ganglion cell axon regeneration (Robin-
son and Madison, 2000). Similar studies establishing the safety of
FG and fibrin-encapsulation have been reported for a range of cell
types, including bone marrow mesenchymal stromal cells (Ahmed
et al., 2011), chondrocytes (Meinhart et al., 1999), carotid artery
derived cells (smooth muscle cells/fibroblast; Cholewinski et al.,
2009), and human neural progenitor cells (Cox et al., 2003).
Tranexamic acid is an antifibrinolytic agent that is used clini-
cally to control bleeding by preventing clotted blood from breaking
down. As FG is essentially a “blood clot,” tranexamic acid was
evaluated for its capacity to stabilize the constructs that on their
own were unstable in culture medium. The addition of tranex-
amic acid stabilized the fibrin scaffolds without adversely affecting
RPC survival or proliferation. Hence, the combination of FG and
tranexamic acid appears to be a suitable as a cell encapsulation and
delivery vehicle.
PROLIFERATION AND DIFFERENTIATION OF RPCs IN FG
While the induction of RPCs from iPS and ES cells has been
demonstrated, optimizing photoreceptor differentiation in these
cultures remains a challenge (Lamba et al., 2006; Lamba et al., 2010;
Assawachananont et al., 2014). Principals that guide photorecep-
tor differentiation from RPCs could be exploited to optimize
www.frontiersin.org February 2015 | Volume 2 | Article 85 | 7
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FIGURE 6 | Line chart showing the effect of different RGD peptides
(GRGDSP and RGDS) on the attachment of RPCs to fibrin-coated
plates as compared to a control peptide (GRGESP). Data were
expressed as mean±SE (n=6). Results were considered significant when
ANOVA was confirmed by Bonferroni post hoc test at p<0.05.
photoreceptor differentiation from a variety of SC sources.
RPCs are undifferentiated, proliferative cells, characterized by the
expression of SOX2, a neural progenitor marker (Klassen et al.,
2007; Steedman et al., 2010), and the absence of CRX, a marker of
post-mitotic photoreceptors and rhodopsin, a late stage marker of
rod photoreceptors (Swaroop et al., 2010). FG-encapsulated RPCs
showed SOX2 and RC expression at days 0 and 3 of culture. SOX2
but not RC was expressed by RPCs grown as monolayer cultures
in our previous studies (Ringuette et al., 2014). The difference
between the two studies could be due to the low levels of growth
factor(s) that would have been incorporated into the FG that was
not present in the RPC culture medium. FG-encapsulated RPCs
lost SOX2 expression and gained CRX expression over time in
the cultures, a result that was corroborated by immunostaining
and gene expression analysis. The inverse relationship between
the differentiation marker CRX and the progenitor marker SOX2
observed in our study is consistent with earlier studies which
revealed that up-regulation of fate-specific markers including
CRX, RC, and rhodopsin (Steedman et al., 2010; Swaroop et al.,
2010) indicates enhanced differentiation of the RPCs toward rod
cell fates. Differentiation of progenitors is accompanied by down-
regulation of SOX2 (Steedman et al., 2010). These results suggest
that the culture environment, possibly the attachment of the
cells to the fibrous scaffold induced a differentiation program in
these cells. This result is consistent with evidence in other studies
that the 3D ECM-like environment promotes RPC differentiation
(Steedman et al., 2010).
A wide range of growth factors are present in trace amount
in the crude form of FG including platelet-derived EGFs, platelet-
derived growth factor A+B (PDGF-AA,AB, BB), TGFα1, TGF-β2,
insulin-like growth factor 1 and 2 (IGF1 and 2), vascular endothe-
lial growth factor (VEGF), and basic FGF-2 that are released from
the platelets (exist in low amount in crude FG) upon activation by
thrombin. In addition to these bioactive factors, exogenous growth
FIGURE 7 | (A) Gene expression analysis of SOX2, CRX, integrin α7, and
integrin β3 after encapsulation of RPCs into FG at 0, 1, 3, and 7 days;
(B) DNA electrophoresis of the real-time PCR products for the different
indicated genes. Monolayer RPCs culture was used as a baseline for each
gene, which was normalized to GAPDH housekeeping expression. Data
were expressed as mean±SE (n=4)
factors were added to the culture medium including EGF, prog-
esterone, and Smoothened agonist (Hh agonist). Growth factors
can either stimulate or inhibit cellular processes such as division,
migration, differentiation, and gene expression, depending on the
cells involved. Therefore, after encapsulation of stem cells, the
combination of growth factors in FG would have a complex effect
on their cellular activity and patterns of gene expression (Ahmed
et al., 2011). Here, the RPCs initiated differentiation but did not
achieve terminal differentiation. It is possible that in vivo graft-
ing may enable the cells to terminally differentiate. RPCs on their
own have failed to engraft or differentiate into retinal neurons,
when transplanted in vivo into mouse eyes (Ringuette et al., 2014).
Hence, this differentiation promoting effect of FG on RPCs, on its
own, or together with incorporated modulatory bioactives, war-
rants further investigation as it could be exploited in the context
of retinal cell transplantation.
RPC–FG SCAFFOLD INTERACTION
Another crucial aspect of retinal tissue engineering is cell attach-
ment to the scaffold surface. To implant RPCs successfully into
the subretinal space, cells must be firmly attached to the scaf-
fold surface and be able to resist shear forces that occur during
implantation. It has been demonstrated that protein modification
of polymeric scaffold can induce attachment of progenitor cells,
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which subsequently promotes the differentiation process (Steed-
man et al., 2010). The present study showed that RPCs exhibited
a spread-out morphology after encapsulation, indicating adhe-
sion and attachment of the cells to FG. This observed attachment
is accompanied by up-regulation of the integrin α7 and β3 genes.
Positive immunostaining for integrin α7 protein was also observed
at the different time points that were consistent with α7 gene
expression. Integrin α7 can bind fibrin (Hinds et al., 2011) and
is thought to be essentially a muscle cell specific receptor (Basora
et al., 1997), as it is a major integrin expressed in skeletal, cardiac,
and smooth muscle (Mielenz et al., 2001). However, non-muscle
locations of integrin α7 expression have been also identified,
including the vasculature, intestinal epithelial cells (Basora et al.,
1997), and nervous system (Velling et al., 1996). It has been also
shown that integrin α7 expression in sensory neuron subtypes
can be induced following nerve injury in mice and mediates neu-
rite outgrowth (Gardiner et al., 2005). In addition, integrin is an
important mediator of axonal outgrowth and regeneration. Inte-
grin α7 is one of the prevalent integrin subunit on neurons and
axons in the developing avian spinal cord (Kil and Bronner-Fraser,
1996) and is concentrated on growth cones in the regenerating
nerve (Werner et al., 2000). Given the precedent for α7 in the ner-
vous system, its expression in the FG-encapsulated RPCs is to be
expected. With respect to integrin β3, studies of normal human
retina and choroid have demonstrated the presence of this sub-
unit in retinal and choroidal blood vessels. In addition, integrin
β3 was expressed in the normal human optic nerve (Elner and
Elner, 1996) and hence, expression may also be expected in RPCs.
It has been shown that fibrin (ogen) mediates attachment and
spreading of many cell types (Chernousov and Carey, 2003). The
lack of inhibitory effect of the two competing RGD peptide on
RPC adhesion to fibrinogen suggests that the attachment of RPCs
to fibrinogen is mediated by a RGD-independent mechanism. This
result is consistent with the evidence for RGD-independent adhe-
sion of integrins α7 and β3 to ECM proteins (Ruoslahti, 1996;
Hynes, 2002; Barczyk et al., 2010; Joddar and Ito, 2011). However,
it has also been shown that β3 also binds to many ECM proteins
through the RGD sequence (Ruoslahti,1996; Joddar and Ito,2011).
It has been shown that α7 integrin is an important laminin recep-
tor and is involved in the formation of the neuromuscular and
myotendinous junctions (Ozeki et al., 2006). In addition, a num-
ber of laminin chains have been shown to be expressed in retinal
basement membranes (Edwards and Lefebvre, 2013). Therefore,
the α7 integrin binding proteins, laminins, are available to nor-
mal RPCs in vivo, which might explain the capability of RPCs to
express α7 integrin in the context of FG.
CONCLUSION
In conclusion, FG is a potential encapsulating material for deliv-
ery of RPCs into the subretinal space in terms of cell proliferation
and survival. FG promoted the adhesion and initiated the dif-
ferentiation of RPCs after encapsulation. Adhesion of RPCs to
FG was mediated by a RGD-independent mechanism. Optimiza-
tion of FG-assisted RPC delivery into the subretinal space will be
needed for further translational efforts. The combination of FG
with bioactive factors such as activin A, taurine, or retinoic acid
(Kicic et al., 2003; Qiu et al., 2007) that promote differentiation
of RPCs; or with incorporated cell adhesive peptides that mod-
ulate cell attachment such as DGEA, RGD,YGYYGDALR, IKVAV,
YIGSR, or RNIAEIIKDI (Ahmed et al., 2008; Joddar and Ito, 2011)
would also be important avenues to explore.
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